Ice announces annual reconstitution changes in the ice biotechnology index
Atlanta & new york--(business wire)--intercontinental exchange, inc. (nyse: ice), a leading global provider of data, technology and market infrastructure, today announced the annual reconstitution of the ice biotechnology index (icebio), which is effective before the open of trading on monday, december 20, 2021. the ice biotechnology index tracks the performance of qualifying u.s. listed biotechnology companies classified within the biotechnology sub-industry group of the ice uniform sector classification schema, which is a multi-asset class industry classification taxonomy developed by ice. the index includes companies that are engaged in the research and development of therapeutic treatments but are not focused on the commercialization and mass production of pharmaceutical drugs. the index also includes companies that are engaged in the production of tools or systems that enable biotechnology processes. “this annual reconstitution ensures that the index maintains its representation of the broader biotechnology industry,” said aram flores, head of index and analytics at ice. “by including companies meeting a minimum threshold of market capitalization and liquidity from multiple u.s. exchanges, the index provides a better gauge of the biotechnology industry and helps improve the investability for users benchmarking to the index.” the following companies will be added to and removed from the index in the december 2021 annual reconstitution: ticker name action abcl abcellera biologics, inc. addition abcm abcam plc sponsored adr addition abos acumen pharmaceuticals, inc. addition absi absci corporation addition acet adicet bio inc addition achl achilles therapeutics plc sponsored adr addition acrs aclaris therapeutics, inc. addition adma adma biologics, inc. addition akus akouos, inc. addition akya akoya biosciences inc addition algs aligos therapeutics, inc. addition alpn alpine immune sciences, inc. addition alvr allovir inc addition ampe ampio pharmaceuticals, inc. addition anvs annovis bio inc addition atai atai life sciences n.v. addition atha athira pharma, inc. addition auph aurinia pharmaceuticals inc. addition autl autolus therapeutics plc sponsored adr addition avir atea pharmaceuticals, inc. addition avte aerovate therapeutics, inc. addition avxl anavex life sciences corp. addition bcab bioatla, inc. addition bcyc bicycle therapeutics plc sponsored adr addition blu bellus health inc. addition bmea biomea fusion inc addition bnr burning rock biotech ltd. sponsored adr class a addition bolt bolt biotherapeutics, inc. addition btx brooklyn immunotherapeutics, inc. addition cadl candel therapeutics, inc. addition cccc c4 therapeutics, inc. addition cdak codiak biosciences, inc. addition cgem cullinan oncology, inc. addition clsd clearside biomedical, inc. addition cmps compass pathways plc sponsored adr addition cmrx chimerix, inc. addition cnta centessa pharmaceuticals plc adr addition cntb connect biopharma holdings ltd. sponsored adr addition crbu caribou biosciences, inc. addition cris curis, inc. addition ctkb cytek biosciences, inc. addition cvac curevac n.v. addition cybn cybin, inc. addition cyt cyteir therapeutics, inc. addition dawn day one biopharmaceuticals, inc. addition dbtx decibel therapeutics, inc. addition dbvt dbv technologies sa sponsored adr addition dnay codex dna, inc. addition dsgn design therapeutics, inc. addition dyn dyne therapeutics inc addition eras erasca, inc. addition etnb 89bio inc addition evlo evelo biosciences, inc. addition ewtx edgewise therapeutics, inc. addition fdmt 4d molecular therapeutics, inc. addition glue monte rosa therapeutics, inc. addition grcl gracell biotechnologies inc. sponsored adr class a addition grph graphite bio, inc. addition grts gritstone bio, inc. addition gth genetron holdings ltd sponsored adr addition hbio harvard bioscience, inc. addition howl werewolf therapeutics, inc. addition huma humacyte, inc. addition icvx icosavax, inc. addition ikna ikena oncology, inc. addition imgo imago biosciences, inc. addition immp immutep ltd sponsored adr addition impl impel neuropharma, inc. addition imrx immuneering corp. class a addition inbx inhibrx inc addition infi infinity pharmaceuticals, inc. addition ipha innate pharma sa sponsored adr addition ipsc century therapeutics, inc. addition janx janux therapeutics, inc. addition kmda kamada ltd addition kmph kempharm, inc. addition knte kinnate biopharma, inc. addition kron kronos bio inc addition kymr kymera therapeutics, inc. addition labp landos biopharma, inc. addition lctx lineage cell therapeutics, inc. addition lptx leap therapeutics, inc. addition lyel lyell immunopharma, inc. addition mbio mustang bio, inc. addition mirm mirum pharmaceuticals, inc. addition morf morphic holding, inc. addition mreo mereo biopharma group plc sponsored adr addition mrus merus n.v. addition mrvi maravai lifesciences holdings inc class a addition mtem molecular templates, inc. addition mtnb matinas biopharma holdings, inc. addition mxct maxcyte, inc. addition naut nautilus biotechnolgy, inc. addition nrxp nrx pharmaceuticals, inc. addition nuvb nuvation bio inc class a addition nuvl nuvalent, inc. class a addition obsv obseva sa addition ocx oncocyte corporation addition olk olink holding ab sponsored adr addition olma olema pharmaceuticals, inc. addition omga omega therapeutics, inc. addition omic singular genomics systems, inc. addition oncr oncorus, inc. addition oyst oyster point pharma inc addition pcvx vaxcyte, inc. addition phat phathom pharmaceuticals, inc. addition pmvp pmv pharmaceuticals, inc. addition prax praxis precision medicines, inc. addition prld prelude therapeutics, inc. addition prqr proqr therapeutics n.v. addition rain rain therapeutics inc addition rani rani therapeutics holdings, inc. class a addition rlyb rallybio corporation addition roiv roivant sciences ltd. addition rxdx prometheus biosciences, inc addition rxrx recursion pharmaceuticals, inc class a addition sana sana biotechnology, inc. addition sbtx silverback therapeutics, inc. addition seer seer, inc. class a addition sesn sesen bio, inc. addition sldb solid biosciences inc. addition smmt summit therapeutics inc addition snse sensei biotherapeutics, inc. addition sqz sqz biotechnologies company addition sttk shattuck labs, inc. addition stvn stevanato group spa addition synh syneos health, inc. class a addition tals talaris therapeutics, inc. addition tern terns pharmaceuticals, inc. addition til instil bio, inc. addition tkno alpha teknova, inc. addition tnya tenaya therapeutics, inc. addition tsha taysha gene therapies, inc. addition verv verve therapeutics, inc. addition virx viracta therapeutics, inc. addition vor vor biopharma, inc. addition vrca verrica pharmaceuticals inc. addition amrs amyris, inc. deletion apre aprea therapeutics, inc. deletion ardx ardelyx, inc. deletion asmb assembly biosciences, inc. deletion bcel atreca, inc. class a deletion cala calithera biosciences, inc. deletion cers cerus corporation deletion cnce concert pharmaceuticals, inc. deletion egrx eagle pharmaceuticals, inc. deletion espr esperion therapeutics, inc. deletion gh guardant health, inc. deletion inzy inozyme pharma, inc. deletion kala kala pharmaceuticals, inc. deletion kldo kaleido biosciences, inc. deletion mnov medicinova, inc. deletion mor morphosys ag sponsored adr deletion ncna nucana plc sponsored adr deletion odt odonate therapeutics, inc. deletion omer omeros corporation deletion siga siga technologies inc deletion supn supernus pharmaceuticals, inc. deletion tlsa tiziana life sciences ltd. deletion ubx unity biotechnology, inc. deletion vrna verona pharma plc sponsored adr deletion vygr voyager therapeutics, inc. deletion xbit xbiotech, inc. deletion ice’s global family of indices serve as the performance benchmark for more than $1 trillion in assets managed by investors around the globe. for more information about ice’s indices, please visit: https://www.ice.com/market-data/indices. about intercontinental exchange intercontinental exchange, inc. (nyse: ice) is a fortune 500 company that designs, builds and operates digital networks to connect people to opportunity. we provide financial technology and data services across major asset classes that offer our customers access to mission-critical workflow tools that increase transparency and operational efficiencies. we operate exchanges, including the new york stock exchange, and clearing houses that help people invest, raise capital and manage risk across multiple asset classes. our comprehensive fixed income data services and execution capabilities provide information, analytics and platforms that help our customers capitalize on opportunities and operate more efficiently. at ice mortgage technology, we are transforming and digitizing the u.s. residential mortgage process, from consumer engagement through loan registration. together, we transform, streamline and automate industries to connect our customers to opportunity. trademarks of ice and/or its affiliates include intercontinental exchange, ice, ice block design, nyse and new york stock exchange. information regarding additional trademarks and intellectual property rights of intercontinental exchange, inc. and/or its affiliates is located here. key information documents for certain products covered by the eu packaged retail and insurance-based investment products regulation can be accessed on the relevant exchange website under the heading “key information documents (kids).” safe harbor statement under the private securities litigation reform act of 1995 -- statements in this press release regarding ice's business that are not historical facts are "forward-looking statements" that involve risks and uncertainties. for a discussion of additional risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see ice's securities and exchange commission (sec) filings, including, but not limited to, the risk factors in ice's annual report on form 10-k for the year ended december 31, 2020, as filed with the sec on february 4, 2021. source: intercontinental exchange ice-corp
